Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...

Single-cell analysis is a ubiquitous laboratory technique that allows researchers to probe the myriad biomolecular states of cells. Single-cell assays can reveal gene and protein expression patterns, ...

Promega Corporation launched a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...

The release of a recent EMA reflection paper, aligning with FDA and WHO positions, has resulted in a renewed focus on the central role of pharmacokinetic (PK) data, the primary status of analytical ...

Disruptive nano-thin plasma coating technology delivers unmatched consistency, clarity, and sustainability BioDep is ...

As interest in CAR T cells and immune-based oncology therapies increases, efficient phenotyping of cell therapy products ...

Axion BioSystems’ Letter of Intent for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular ...

Company to showcase highly scalable and versatile capsule technology at the AGBT 2026 General Meeting Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced ...

This article is based on a poster originally authored by Blaise Louis, Serena Belluschi, Daniel Weekes, Tom Mitchell, Holly Herbert, Tarun Vemulkar and Jeroen Verheyen, which was presented at ELRIG ...

The disposition of antibody-based therapeutics is generally determined by both target-mediated and non-target processes, the latter being an often-overlooked aspect. Target-independent liabilities can ...